ConductScience.org, home

Paper26318836

Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.

Gracies JM and 17 others. Lancet Neurol, 2015. Cited by 160 papers, by iCite.

Cite this record

ConductScience Library. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial. Papers, record 26318836. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26318836

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
PubMed
Journal
Lancet Neurol
PubMed
Year
2015
PubMed
Publication types
Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
160
iCite
Relative citation ratio, by iCite
8.35
iCite
Revised in PubMed
2026-05-18
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gracies JMJean-Michel
2Brashear AAllison
3Jech RRobert
4McAllister PPeter
5Banach MMarta
6Valkovic PPeter
7Walker HHeather
8Marciniak CChristina
9Deltombe TThierry
10Skoromets AAlexander
11Khatkova SSvetlana
12Edgley SSteven
13Gul FFatma
14Catus FFrance
15De Fer BBBeatrice Bois
16Vilain CClaire
17Picaut PPhilippe
18International AbobotulinumtoxinA Adult Upper Limb Spasticity Study GroupGroup

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acetylcholine Release InhibitorsMajor topic
Botulinum Toxins, Type AMajor topic
Brain InjuriesMajor topic
Muscle SpasticityMajor topic
ParesisMajor topic
StrokeMajor topic
Upper ExtremityMajor topic
Adult
Double-Blind Method
Female
Humans
Injections, Intramuscular
Male
Middle Aged
Treatment Outcome

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01313299Dysport® Adult Upper Limb SpasticityDerived from the trialYesClinicalTrials.gov
NCT07744659Spinal Cord Stimulation for Poststroke SpasticityBackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in26318835Botulinum toxin A for upper limb spasticity.https://conductscience.org/library/papers/26318835

Source PubMed

Download CSV of comments and corrections

Cited by98

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.

PMIDTitleJournalYearIn PapersSource
42931520Active Function Improvement with Repeated Injections of Botulinum Toxin A in Upper Limb Spasticity: A Longitudinal Analysis from the ULIS-III Study.Toxins (Basel)2026https://conductscience.org/library/papers/42931520PubMed
42900276Modulating the WNK1-SPAK/OSR1-KCC2 Pathway: Acupuncture's Therapeutic Potential in Mitigating Muscle Hypertonia in Ischemic Stroke Rats.Neurochem Res2026https://conductscience.org/library/papers/42900276PubMed
42784322Goal Attainment and Outcome Evaluation for Upper and Lower Limb Spasticity: A Real-Life Cohort Analysis in a Community-Based Outreach Service.Toxins (Basel)2026https://conductscience.org/library/papers/42784322PubMed
42662793Spastic co-contraction: A misdirected central command.Clin Neurophysiol Pract2026https://conductscience.org/library/papers/42662793PubMed
42603267Shockwave Therapy or Acupoint Stimulation Combined With Physiotherapy for Spasticity and Motor Function in Post-Stroke Recovery: A Randomized Controlled Trial.Brain Behav2026https://conductscience.org/library/papers/42603267PubMed
42525344Spastic Hypertonia Following Middle Cerebral Artery Occlusion in Rats: Assessment of Behavioral, Electrophysiological, and Morphological Parameters in Dynamics.Bull Exp Biol Med2026https://conductscience.org/library/papers/42525344PubMed
42387889Identification of spastic muscles involved in abnormal joint posture in patients with upper motor neuron syndrome: a narrative review.J Rehabil Med2026https://conductscience.org/library/papers/42387889PubMed
42159955A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity.Adv Ther2026https://conductscience.org/library/papers/42159955PubMed
42047510
Evolution of goal setting and attainment over repeated cycles of botulinum toxin A for upper limb spasticity in real-life clinical practice: longitudinal analyses from the observational ULIS-III cohort study.
J Rehabil Med2026https://conductscience.org/library/papers/42047510PubMed
41745769Cell-Penetrating Botulinum Neurotoxin Type A Proteins Alleviate Skeletal Muscle Hypertrophy with Associated Alterations of Mitochondrial Homeostasis.Toxins (Basel)2026https://conductscience.org/library/papers/41745769PubMed
41733858Electromyographic features for quantitative assessment of lower limb spasticity after stroke: a feasibility study.Med Biol Eng Comput2026https://conductscience.org/library/papers/41733858PubMed
41591197Longitudinal, Multi-Cycle Evaluation of Passive Function Improvement in People with Arm Spasticity Treated with Botulinum Toxin A.Toxins (Basel)2026https://conductscience.org/library/papers/41591197PubMed
41537530Real-world use of botulinum toxin-A for post-stroke spasticity in the Netherlands: a retrospective claims study.J Rehabil Med2026https://conductscience.org/library/papers/41537530PubMed
41306956Tailoring BoNT A treatment and assessment across recovery stages after stroke: a report of four clinical cases.J Med Life2025https://conductscience.org/library/papers/41306956PubMed
40979203Constraint-induced movement therapy reduced shoulder pain and improved function in subacute and chronic stroke: a cohort study.Front Neurol2025https://conductscience.org/library/papers/40979203PubMed
40881626Potential impacts of acupuncture on motor function recovery after ischemic stroke: insights from basic and clinical studies.Front Cell Neurosci2025https://conductscience.org/library/papers/40881626PubMed
40864061Pathways for Diagnosis and Multimodal Management, Including Botulinum Neurotoxin Therapy, in Shoulder Conditions Following Acquired Central Nervous System Lesions.Toxins (Basel)2025https://conductscience.org/library/papers/40864061PubMed
40678290Reliability of the Five Step Assessment and Its Coefficients of Impairment in Spastic Paresis.Arch Rehabil Res Clin Transl2025https://conductscience.org/library/papers/40678290PubMed
40137890Pain Reduction with Repeated Injections of Botulinum Toxin A in Upper Limb Spasticity: A Longitudinal Analysis from the ULIS-III Study.Toxins (Basel)2025https://conductscience.org/library/papers/40137890PubMed
40021946Effects of Electroacupuncture on Syt3 and GluA2 in Rats With Limb Spasms After Intracerebral Hemorrhage.Brain Behav2025https://conductscience.org/library/papers/40021946PubMed

See all 98 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26318836

GET https://conductscience.org/api/papers/v1/26318836/cited_by?page=2